Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

1.41
Delayed Data
As of May 29
 +0.07 / +5.22%
Today’s Change
1.19
Today|||52-Week Range
1.95
+1.44%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close1.34
Today’s open1.39
Day’s range1.38 - 1.45
Volume4,103,144
Average volume (3 months)1,315,719
Market cap$271.3M
Dividend yield--
Data as of 4:00pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)-36.36%
Earnings growth (next 5 years)--
Revenue growth (last year)+3.31%
P/E ratioNM
Price/Sales10.03
Price/Book3.73

Competitors

 Today’s
change
Today’s
% change
ECYTEndocyte Inc-0.06-0.98%
TKAITokai Pharmaceutical...-0.02-0.18%
VVUSVIVUS Inc+0.02+0.80%
GALEGalena Biopharma Inc-0.06-3.68%
Data as of 4:00pm ET, 05/29/2015

Financials

Next reporting dateJuly 13, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$22.4M
Annual profit (last year)-$35.4M
Net profit margin-157.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
CFO &
Principal Accounting Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers